tiprankstipranks
Trending News
More News >
Coherus Biosciences (CHRS)
:CHRS
US Market

Coherus Biosciences (CHRS) Balance Sheet

Compare
1,637 Followers

Coherus Biosciences Balance Sheet

Coherus Biosciences's total assets for Q3 2025 were $516.52M, an increase of 17.53% from the previous quarter. CHRS total liabilities were $428.75M for the fiscal quarter, a 34.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 448.53M$ 629.60M$ 480.85M$ 679.33M$ 841.65M
Total Liabilities
$ 580.52M$ 823.03M$ 618.26M$ 581.61M$ 560.67M
Total Equity Gross Minority
$ -131.99M$ -193.43M$ -137.42M$ 97.73M$ 280.97M
Other Metrics
Currency in USD

Coherus Biosciences Debt to Assets